Health Care Reform Plan Focuses On Three Priorities
This article was originally published in PharmAsia News
Executive Summary
China's Ministry of Health has prioritized three areas in health care reform that it will focus on the later half of this year: (1) working with relevant authorities, the ministry will solicit public opinions and amend the health plan, especially including new knowledge and ideas established during the earthquake relief; (2) complete the drafting and revision of complementary documents in tandem with the reform plan's dissemination, deployment and implementation; and (3) deepen the preparations of pilot programs for the reform plan by considering the principles, criteria and procedures for location selection. At the same time, MOH is studying and formulating the strategic planning of Healthy China 2020. (Click here for more - Chinese Language)
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.